Long-term (4-year) safety of intravenous Ibandronate in metastatic breast cancer: an open-label study
M Pecherstorfer, I.J Diel, B BergstromVolume:
2
Year:
2004
Language:
english
DOI:
10.1016/s1359-6349(04)90858-0
File:
PDF, 172 KB
english, 2004